Trial Profile
Cardiovascular and Functional Effects of Testosterone Therapy for Hypogonadal Patients With Heart Failure
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Testosterone (Primary)
- Indications Heart failure; Hypogonadism
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 14 Jul 2017 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 07 Jul 2011 Planned initiation date changed from 1 Jun 2011 to 1 Jul 2011 as reported by ClinicalTrials.gov.
- 24 Jun 2011 New trial record